AVITA MEDICAL, INC. — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$18M↓-4.3%
2025-09-30$17M↓-12.7%$-13M↑+18.6%-53.6%
2025-06-30$18M↑+21.2%$-10M↑+35.6%-60.5%
2025-03-31$19M↑+66.7%$-14M↑+25.7%-63.9%
2024-12-31$18M↑+29.7%
2024-09-30$20M↑+43.2%$-16M↓-86.0%-70.6%
2024-06-30$15M↑+29.3%$-15M↓-48.2%-102.8%
2024-03-31$11M↑+5.3%$-19M↓-102.4%-155.0%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$18M
↓-4.3% -$791K YoY
Net Income
$7M
↓-30.4% -$3M YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 32 quarters

margin trajectory tells the operating-leverage story
Gross Margin↓-6.4pts
81.2%
Operating Margin↑+17.0pts
-53.6%
Net Margin↑+5.6pts
-77.3%

Go deeper